dapsone

(redirected from Aczone)
Also found in: Dictionary, Thesaurus, Medical.

dapsone

[′dap‚sōn]
(pharmacology)
4,4′-sulfonyldianiline
References in periodicals archive ?
Aczone 7.5% gel is a stronger iteration than the first generation topical dapsone product (5%), but deceased recommended dosing to once daily appears to result in excellent tolerability.
Joshua Zeichner, a once-daily application of Aczone Gel 7.5%, "in the largest pivotal trial program conducted for FDA approval of a topical acne drug," was clinically proven to be effective and safe in treating inflammatory and comedonal acne in 12 weeks.
Pharmaceutical company Allergan (NYSE:AGN) disclosed on Thursday the receipt of approval from the US Food and Drug Administration (FDA) to market ACZONE Gel, 7.5%, a new prescription topical treatment for acne in patients 12 years of age and older.
The company said the ACZONE (dapsone) Gel, 7.5% delivers proven efficacy to treat both inflammatory and non-inflammatory acne, with a new concentration of dapsone in just once-a-day application.
That requirement, which came as a condition of FDA approval of Aczone in 2005, had convinced the drug's manufacturer, QLT Inc., that topical dapsone was not a marketable drug.
The Food and Drug Administration approved Aczone (dapsone) Gel, 5% for the topical treatment of acne vulgaris in patients 12 years old and older.
M2 EQUITYBITES-February 26, 2016-Allergan passes US FDA's approval for ACZONE Gel, 7.5% for treating acne in patients 12 years of age and older in once daily dosing
A potential topical therapy for rosacea worth keeping an eye on is dapsone gel 5% (Aczone), he said.
M2 EQUITYBITES-February 9, 2011-Valeant Pharmaceuticals International Inc acquires licence to ACZONE Gel 5% in Canada(C)2011 M2 COMMUNICATIONS http://www.m2.com
has acquired QLT Inc.'s Aczone (dapsone) gel 5%, a topical treatment for acne.